Matches in SemOpenAlex for { <https://semopenalex.org/work/W2263668130> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2263668130 endingPage "8" @default.
- W2263668130 startingPage "752" @default.
- W2263668130 abstract "(+)-8,9-Dihydro-10-dihydro-10-methyl-7-[(5-methyl-4-imidazolyl) methyl]pyrido-[1,2-a]indol-6(7H)-one hydrochloride (FK1052) is a newly designed and synthesized 5-hydroxytryptamine (5-HT)3 receptor antagonist with 5-HT4 receptor antagonistic activity. This compound, as well as ondansetron and granisetron, dose-dependently inhibited the von Bezold-Jarish reflex, a 5-HT3 receptor-mediated response, after intravenous (i.v.) and intraduodenal (i.d.) dosing to rats. The ID50 values showed FK1052 (0.28 microgram/kg, i.v., 5.23 micrograms/kg, i.d.) to be more potent than ondansetron (5.23 micrograms/kg, i.v., 170 micrograms/kg, i.d.) and granisetron (0.70 micrograms/kg, i.v., 66 micrograms/kg, i.d.). Furthermore, bioavailabilities of the test drugs by ID50 ratio (i.d./i.v.) showed that FK1052(17) was better absorbed than ondansetron(33) and granisetron(94) and possessed a similar duration of action to that of ondansetron and granisetron. We also examined the effects on 2-methyl-5-HT-, 5-HT- and 5-methoxytryptamine-induced contractions of guinea pig isolated ileum. FK1052, ondansetron and granisetron concentration-dependently inhibited 2-methyl-5-HT, a 5-HT3 agonist-induced contraction. The pA2 values for the 5-HT3 receptor indicated that FK1052 (8.36) was 40 times and three times more potent than ondansetron (6.79) and granisetron (7.86), respectively. FK1052, unlike ondansetron and granisetron, inhibited the 5-HT4-mediated component of concentration-response curve to 5-HT. Furthermore, FK1052 suppressed 5-methoxytryptamine, a 5-HT4 agonist-induced contraction in a concentration-dependent but insurmountable manner.(ABSTRACT TRUNCATED AT 250 WORDS)" @default.
- W2263668130 created "2016-06-24" @default.
- W2263668130 creator A5017707745 @default.
- W2263668130 creator A5027858721 @default.
- W2263668130 creator A5032606320 @default.
- W2263668130 creator A5038707550 @default.
- W2263668130 creator A5044071858 @default.
- W2263668130 creator A5062061619 @default.
- W2263668130 date "1993-05-01" @default.
- W2263668130 modified "2023-09-23" @default.
- W2263668130 title "Pharmacological characterization of FK1052, a dihydropyridoindole derivative, as a new serotonin 3 and 4 dual receptor antagonist." @default.
- W2263668130 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8496821" @default.
- W2263668130 hasPublicationYear "1993" @default.
- W2263668130 type Work @default.
- W2263668130 sameAs 2263668130 @default.
- W2263668130 citedByCount "5" @default.
- W2263668130 crossrefType "journal-article" @default.
- W2263668130 hasAuthorship W2263668130A5017707745 @default.
- W2263668130 hasAuthorship W2263668130A5027858721 @default.
- W2263668130 hasAuthorship W2263668130A5032606320 @default.
- W2263668130 hasAuthorship W2263668130A5038707550 @default.
- W2263668130 hasAuthorship W2263668130A5044071858 @default.
- W2263668130 hasAuthorship W2263668130A5062061619 @default.
- W2263668130 hasConcept C126322002 @default.
- W2263668130 hasConcept C170493617 @default.
- W2263668130 hasConcept C185592680 @default.
- W2263668130 hasConcept C2775864247 @default.
- W2263668130 hasConcept C2776885963 @default.
- W2263668130 hasConcept C2777170512 @default.
- W2263668130 hasConcept C2777452722 @default.
- W2263668130 hasConcept C2778122271 @default.
- W2263668130 hasConcept C2778938600 @default.
- W2263668130 hasConcept C2780204788 @default.
- W2263668130 hasConcept C2780852908 @default.
- W2263668130 hasConcept C2780884295 @default.
- W2263668130 hasConcept C53910766 @default.
- W2263668130 hasConcept C55493867 @default.
- W2263668130 hasConcept C71924100 @default.
- W2263668130 hasConcept C98274493 @default.
- W2263668130 hasConceptScore W2263668130C126322002 @default.
- W2263668130 hasConceptScore W2263668130C170493617 @default.
- W2263668130 hasConceptScore W2263668130C185592680 @default.
- W2263668130 hasConceptScore W2263668130C2775864247 @default.
- W2263668130 hasConceptScore W2263668130C2776885963 @default.
- W2263668130 hasConceptScore W2263668130C2777170512 @default.
- W2263668130 hasConceptScore W2263668130C2777452722 @default.
- W2263668130 hasConceptScore W2263668130C2778122271 @default.
- W2263668130 hasConceptScore W2263668130C2778938600 @default.
- W2263668130 hasConceptScore W2263668130C2780204788 @default.
- W2263668130 hasConceptScore W2263668130C2780852908 @default.
- W2263668130 hasConceptScore W2263668130C2780884295 @default.
- W2263668130 hasConceptScore W2263668130C53910766 @default.
- W2263668130 hasConceptScore W2263668130C55493867 @default.
- W2263668130 hasConceptScore W2263668130C71924100 @default.
- W2263668130 hasConceptScore W2263668130C98274493 @default.
- W2263668130 hasIssue "2" @default.
- W2263668130 hasLocation W22636681301 @default.
- W2263668130 hasOpenAccess W2263668130 @default.
- W2263668130 hasPrimaryLocation W22636681301 @default.
- W2263668130 hasRelatedWork W1984231551 @default.
- W2263668130 hasRelatedWork W2001479739 @default.
- W2263668130 hasRelatedWork W2014169505 @default.
- W2263668130 hasRelatedWork W2017383257 @default.
- W2263668130 hasRelatedWork W2072939107 @default.
- W2263668130 hasRelatedWork W2074816348 @default.
- W2263668130 hasRelatedWork W2396279013 @default.
- W2263668130 hasRelatedWork W2402349415 @default.
- W2263668130 hasRelatedWork W130043472 @default.
- W2263668130 hasRelatedWork W1913503189 @default.
- W2263668130 hasVolume "265" @default.
- W2263668130 isParatext "false" @default.
- W2263668130 isRetracted "false" @default.
- W2263668130 magId "2263668130" @default.
- W2263668130 workType "article" @default.